Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy

BackgroundLenvatinib monotherapy and combination therapy with immune checkpoint inhibitors (ICI) were widely applied for unresectable hepatocellular carcinoma (uHCC). However, many patients failed to benefit from the treatments. A prognostic model was needed to predict the treatment outcomes and gui...

Full description

Bibliographic Details
Main Authors: De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, Jia-Yan Yan, Yu-Peng Wang, Ya Cao, Sheng-Xiang Rao, Jia Fan, Xin-Rong Yang, Ao Huang, Jian Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
predicting model
liver cancer
lenvatinib
immunotherapy
protein induced by vitamin K absence or antagonist-II
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1141199/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1141199/full

Similar Items